Boston Scientific (BSX) Stock Forecast & Price Target
Score
Boston Scientific Corporation price target
| BSX | |
|---|---|
| Low | $46.00 |
| Average | $54.65 |
| High | $71.00 |
| Upside vs current price | +23.3% |
The average target of $54.65 is +23.3% versus the current BSX price of $44.34.
Boston Scientific Corporation analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 6 |
| Buy | 14 |
| Hold | 11 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
31 analysts cover BSX.
Boston Scientific Corporation EPS and revenue estimates
BSX shows the next fiscal years with at least three analysts: 2026 EPS $3.16, 2027 EPS $3.13. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $3.16 | $20.98B |
| 2027 | $3.13 | $20.88B |
Is Boston Scientific Corporation a buy or sell?
Of the 31 analysts covering Boston Scientific Corporation, 20 rate it a buy (6 strong buy and 14 buy), 11 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The BSX consensus label is Buy, beside 20 buy-side ratings and 0 sell-side ratings.
The average target of $54.65 implies +23.3% versus the current price of $44.34.
Those 31 ratings on BSX are a headcount, and the label on file is Buy.
Reading the Boston Scientific Corporation forecast
The BSX target range is wide: $46.00 at the low end, $54.65 in the middle, and $71.00 at the top.
Set next to the $44.34 BSX quote, that average is +23.3%.
The BSX ratings are split: 20 of 31 analysts are on the buy side, 11 are at hold, and 0 are on the sell side, and the published consensus is Buy.
Recent actions on BSX lean down: 4 downgrades and 0 upgrades.
The average BSX target over the last month is $50.00, below the $51.44 quarterly average.
31 analysts publish on BSX, so one note does not swing the average by itself.
Boston Scientific Corporation forecast questions
What is the BSX price target?
The published range for BSX is $46.00 to $71.00, with an average of $54.65. That average is +23.3% versus the current price of $44.34.
Is Boston Scientific Corporation a buy or sell?
Of the 31 analysts covering Boston Scientific Corporation, 20 rate it a buy, 11 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the BSX headcount is 20 buy, 11 hold, and 0 sell.
What is the EPS estimate for Boston Scientific Corporation?
Analyst EPS estimates for Boston Scientific Corporation: 2026 $3.16, 2027 $3.13.
What is the revenue estimate for Boston Scientific Corporation?
Analyst revenue estimates for Boston Scientific Corporation: 2026 $20.98B, 2027 $20.88B.
How many analysts cover BSX?
31 analysts cover BSX. Their consensus on BSX is Buy, across those 31.